FDA Investigator Gene R Gunn

Gene R Gunn has inspections in 23 countries as of 01 Nov 2023. Gene R Gunn has collaborated with a combinined 3597 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
207
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, United States of America, Germany, France, Netherlands, Canada, Spain, Belgium, Argentina, Romania, Poland, Brazil, United Kingdom of Great Britain and Northern Ireland, Saint Lucia, South Africa, Czechia, Jordan, Philippines, Turkey, Belarus, Hungary, Latvia, Belize
Co-Investigator(s):
Aaron J Fox, Ademola O Daramola, Adrienne D Thompkins, Alanna Lmussawwir Bias, Alexander M Kay, Alicia M Mozzachio, Ana P Barido, Andrea A Branche, Andrea H Norwood, Angela E Glenn, Angela Shepas, Annette Melendez, Anthony J Grace, Arindam Dasgupta, PhD, Ashley B Jelonek, Atul J Agrawal, Audrey J Yarbrough, Barbara T Carmichael, Bill Tacket, Jr, Billy M Battles, Bora Veliu, Brant M Schroeder, Brunidla Torres, Brunilda Torres, Byungja E Marciante, Camille D Brown, Carla A Norris, Carmen Y Fisher, Carol S Davis, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charles R Bonapace, PhD, Chinyere A Asanya, Christie A Soto, Cierra S Strong, Clara E Santiago, Courtney A Gilbert, Courtney N Long, Craig A Garmendia, Craig T Rybus, Damaris Y Hernandez, Dana M Klimavicz, Daniel J Roberts, Daniel L Aisen, Darcy L Webber, Daryl A Dewoskin, David J Leray, David P King, Dawn C Olenjack, Dillard H Woody, Jr, Dina A Tallman, Dipesh K Shah, Donald M Mack, Douglas Florentino, Dr. Barbara D Paul, PhD, Dustin P Tran, Edward J Janik, Edwards, Edwin J Gorney, Emily A Baldwin, Emily A Green, Emily S Baldwin, Eric M Mueller, PharmD, Ernest A Clausnitzer, Ethan P Stegman, Felix Maldonado, Gajendiran Mahadevan, PhD, Geoffrey K Kilili, Glenn S Quintanilla, Harry R Bringger, Jr, Hasan A Irier, PhD, Holly M Scott, Howard A Webley, Hunt, Iris C Macinnes, James P Mcevoy, Jana L Caylor, Jason D Tenney, Jason P Aun, Jennifer A Robinson, Jennifer C Adams, Jennifer C Johnson, Jessica L Pressley, Joanne E King, Joanne M Schlossin, John A Iwen, John B Crowe, Jolanna A Norton, Joseph L Despins, PhD, Joshua J Silvestri, Kara A Scheibner, PhD, Karen M Montgomery (KMM), Karl D Hezel, Kassa Ayalew, MD, Kathleen B Swat, Kathryn A Krentz, Kathryn Suttling, Keith A Schwartz, Kelly I Anderson, Kham Phommachanh, Kimberly A Dux, Kip J Hanks, Kirtida Patel, Ladislav Kermet, Latrice G Jones, Laura B Kennedy, Laura E Garcia, LCDR Michael H Tollon, LCDR Randall L Morris, Leo J Lagrotte, Leon L Crawley, Leroy Terrelonge, Leslie A Cartmill, Leslie A Jackanicz, Linda K Matheny, Lisa A Warner, Lissette Paiz, Lori A Gioia, LT Daveta L Bailey, LT Kimberly M Hull, LT Richard A Lyght, Lucas B Leake, Lundy H Patrick, Madelyn Renteria, Makini Cobourne Duval, PhD, Marc Balzarini, Mathew T Thomas, MD, Matthew B Thomaston, Melanie G Warzala, Melanie W Pishnery, Melinda B Lewis, Meredith M Andress, Meredith M Cobb, Michael C Lombardi, Michelle C Roberts, Miguel A Martinez, Mizanne E Lewis, Myra K Casey, Nancy A Bellamy, Nebil A Oumer, Nicola M Fenty Stewart, Nicolas Riveratorres, Nicole E Knowlton, Noreen Muniz, Noreen Muñiz, Ormond, Pamela L Vega, Patrick C Dooley, Paul L Figarole, Jr, Peter E Baker, Peter Kessler, PhD, Peter R Lenahan, Rafael E Arroyo, Ralph A Erickson, Raymond T Oji, Regina T Brown, Reynolds, Richard K Vogel, Richard W Berning, Robert D Tollefsen, Rodney W Lenger, Roger F Zabinski, Ronnie E Jackson, Ruben C Ayala, PharmD, Salvatore N Randazzo, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Scott B Laufenberg, Sharon Giamberini, Sheri L Stephenson, Shirley H Isbill, Sonia M Monges, Sri Ramakrishnaiah Yellela, Stacey F Allard, Stacey F Rivette, State Agency, Steven A Brettler, Stuart W Russell, Susan D Yuscius, Susan K Cummins, MD, MPA, Susanne M Richardson, MSc RAC ELS, Taichun Qin, PhD, Tamil Arasu, PhD, Tara K Carmody, Tawny L Colling, Teresa M Hillebrandt, Terri E Gibson, Thomas J Hudson, Tiara Nbrown Crosen, Traci M Armand, Tracy L Reed, Travis M Beard, Truong Xuan Nguyen (Andy), Virginia L Meeks, Young M Choi, PhD, Yvins Dezan, Zerita White

Gene R Gunn's Documents

Publish Date Document Type Title
September, 2011 EIR James A. Reeves, MD - EIR, 2011-09-16
November, 2013 FDA 483 Ramon A. Gil, M.D. - Form 483, 2013-11-22
August, 2016 FDA 483 Jeffrey Lancet, M.D. - Form 483, 2016-08-24
July, 2017 EIR Cognitive Research Corporation - EIR, 2017-07-14
June, 2011 FDA 483 Tawee Tanvetyanon - Form 483, 2011-06-07
November, 2013 EIR Ramon A. Gil, M.D. - EIR, 2013-11-22
February, 2014 EIR Synexus Clinical Research US, Inc. - EIR, 2014-02-05
December, 2012 FDA 483 Rosario Hidalgo, MD - Form 483, 2012-12-04
May, 2014 EIR Baz, Rachid C. M.D. - EIR, 2014-05-12
September, 2011 FDA 483 James A. Reeves, MD - Form 483, 2011-09-16
January, 2018 FDA 483 Poly Pharmaceuticals, Inc. - Form 483, 2018-01-24
August, 2019 EIR Ghulam Mufti, MBBS, DM - EIR, 2019-08-09
March, 2015 FDA 483 Moore Clinical Research Inc. - Form 483, 2015-04-08
September, 2011 FDA 483 Response James A. Reeves, MD - Form 483R, 2011-10-05
April, 2021 EIR Loreto Hierro, MD - EIR, 2021-04-16
November, 2011 EIR Vernon Sondak - EIR, 2011-11-03
February, 2014 EIR BayCare Health Systems IRB - EIR, 2014-02-19
December, 2012 EIR Rosario Hidalgo, MD - EIR, 2012-12-04
February, 2015 FDA 483 Geoffrey T. Gibney, MD - Form 483, 2015-02-11
April, 2012 EIR Thomas Ervin - EIR, 2012-04-12
June, 2014 FDA 483 Wells Pharmacy Network LLC - Form 483, 2014-06-19
August, 2013 EIR AXIS Clinicals Limited - EIR, 2013-08-08
June, 2014 FDA 483 Wells Pharmacy Network LLC - Form 483, 2014-03-07
April, 2013 FDA 483 Moore Clinical Research Inc. - Form 483, 2013-04-02
January, 2023 FDA 483 Banji Awosika, M.D. - Form 483, 2023-01-27
May, 2014 FDA 483 Response Baz, Rachid C. M.D. - Form 483R, 2014-05-29
August, 2019 EIR Katja Sockel - EIR, 2019-08-16
September, 2012 EIR Javier Pinila-Ibarz, M.D., Ph.D. - EIR, 2012-09-11
January, 2018 EIR Poly Pharmaceuticals, Inc. - EIR, 2018-01-24
June, 2017 FDA 483 Nikhil Khushalani - Form 483, 2017-06-23
January, 2023 FDA 483 Kwabena (NMI) Ayesu, M.D. - Form 483, 2023-01-27
June, 2013 FDA 483 Agnes E. Ubani, MD - Form 483, 2013-06-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more